TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

MLTX COURT ALERT: MoonLake Immunotherapeutics Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by December 15

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bleichmar Fonti & Auld Llp
MLTX COURT ALERT: MoonLake Immunotherapeutics Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by December 15

MoonLake Immunotherapeutics faces a securities fraud lawsuit after reporting disappointing Phase 3 VELA trial results for its investigational drug sonelokimab, causing its stock price to drop nearly 90%.

Insights
MLTX   negative

Stock price collapsed by 90% after failed clinical trials, potential misrepresentation of clinical data, and lawsuit alleging securities fraud